As an MSCA Doctoral Network, dIscOverNET aims to implement a higly innovative Doctoral Program, bringing together interdisciplinary and intersectoral experts of universities, research institutions and infrastructures, businesses including SMEs, and other socio-economic actors from different countries across Europe and beyond to explore the potential of leveraging the immune system for the treatment of NET, aiming to induce durable anti-tumor responses.
The proposed research will focus on NET from the gastroenteropancreatic tract and lung as they make up 94% of all NEN and are clinically and biologically very distinct from NEC. By systematically adapting and optimizing next-generation immune-driven strategies for NET, dIscOverNET strives to unlock its efficacy through modulation of the tumor immune microenvironment (TIME).
Fifteen Doctoral Candidates will participate in the dIscOverNET project, equipping them with strong academic foundations and a comprehensive set of transferable skills, together with international, interdisciplinary, and intersectoral exposure. This will help them take on leading roles in Europe, thereby increasing awareness of NET biological complexity and the immunotherapy potential, thus enabling more basic research as well as clinical NET trials and integrated research efforts in the coming years.